Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
When brain cells cannot communicate normally, thinking, behavior and feelings can be affected
Your review * Works great and fast shipping Loved loved loved the experience with Vitastir
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
Statements regarding their efficacy have not been evaluated by the FDA
Clinical benefits - Improved skin plumpness
US$ 25.65
US$ 20.49
US$ 23.72
US$ 24.84
US$ 28.78
US$ 26.37